Explore Business Standard
Associate Sponsors
Co-sponsor
Ahmedabad (Gujarat), Apr 11 (ANI): Manufacturing of Hydroxychloroquine tablets has been paced up by Indian pharmaceutical giant Zydus Cadila's Ahmedabad manufacturing unit. There has been an increase in the demand of the tablets all over the world after the drug deemed to be useful in dealing with COVID-19. Zydus Cadila CEO Pankaj Patel had informed that the company will produce around 15 crore tablets by next month.